Navigation Links
Amylin Pharmaceuticals to Present at Goldman Sachs Annual Global Health Care Conference
Date:6/3/2009

SAN DIEGO, June 3 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Goldman Sachs Annual Global Health Care Conference on Tuesday, June 9, 2009 at 10:45 a.m. ET / 7:45 a.m. PT in New York. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview.

The live presentation and breakout session will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate Web site, located at www.amylin.com. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California. Further information about Amylin Pharmaceuticals is available at www.amylin.com.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...swire-FirstCall/ - Oncolytics Biotech Inc. ("Oncol...announced today that in connection with its previo...e exercised in full their over-allotment option an... is comprised of one common share and 0.4 of a com...e of US$3.00 per unit. Each whole common share pur...
(Date:12/2/2009)... December 2 Gamida Cell announced ...al (animal study) safety and,efficacy of a gene th...,Cornell Medical College and Gamida Cell. The prod...such as Cooley,s Anemia. , Gamida Cell is... vivo,populations of stem/progenitor cells. The c...
(Date:12/2/2009)...re-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AE...ceutical company focused on endocrine therapy and ...rug Administration (FDA) has granted Fast Track de...itor compound, perifosine (KRX-0401), for the trea...yx Biopharmaceuticals, Inc. ("Keryx") ( KERX), is ...
(Date:12/1/2009)...on announced that he has joined Carolina Eyecare P...at www.DrKerrySolomon.com , which was developed b...en LASIK, lens implant, and cataract surgery exper...ubstantial contributions to improving vision corre...rgeons, which screens LASIK surgeons based upon ex...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
...T WAYNE, Ind., Aug. 7 The Alliance for Research i... 3rd annual international,conference will be held ...urdue University Fort Wayne (IPFW) campus., For o... web site, http://www.a4rimm.org/ , "This year,s ... the,Science of Healing," says Dr. Angela LaSalle,...
...KING RIDGE, N.J., Aug. 7 Heritage Labs, a,divisio...the Appraise(R) Home,A1c Kit, a new at-home consum... level of diabetics and potential diabetics. The A... inexpensive and easy-to-use blood test,that produ...valent to whole,blood tests collected in physician...
...ADENA, Calif., Aug. 7 AutoImmune Inc. (OTC,Pink S... or $0.01 per share,basic and diluted, for the thr... loss of $62,000, or break even per share basic an...7. For the six months ended June 30, 2008,the net ...luted, compared,with net loss of $54,000, or break...
Other Biology Technology:The Science of Music Meets the Art of Medicine - ARIMM 3rd Annual Conference at IPFW, September 12-13, 2008 2Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test 2Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test 3Hooper Holmes' Heritage Labs Division Launches New Home Diabetes Test 4AutoImmune Inc. Reports 2008 Second Quarter Financial Results 2AutoImmune Inc. Reports 2008 Second Quarter Financial Results 3
(Date:12/4/2009)...tivity in organs relevant for coronary artery dise...rsity Karolinska Institutet have identified a modu...of white blood cells into the atherosclerotic plaq... open-access journal PLoS Genetics , suggest that...he development of atherosclerosis may help to redu...
(Date:12/4/2009)... of heart cells, University of Iowa investigators ...lmodulin kinase II (CaM kinase), disrupts the elec...hich also involved Columbia University, was publis...al Biology . , "Recently, researchers have deve...critical regulator of the heart,s response to inju...
(Date:12/3/2009)...ormation and adapt to changes in our daily environ...ars to lie in the minute junctions where nerve cel...ngone Medicine Center researchers. The study is pu... , The scientists, led by Wen-Biao Gan, PhD, ass... NYU School of Medicine, discovered that a delicat...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2Sunlight May Cause Rash in Autoimmune Disease 53903 1Sunlight May Cause Rash in Autoimmune Disease 53903 2Vitamin Shoppe Industries Inc to Discuss Second Quarter 2009 for Bondholders 53899 1AMN Healthcare Announces Second Quarter 2009 Results 53895 1AMN Healthcare Announces Second Quarter 2009 Results 53895 2AMN Healthcare Announces Second Quarter 2009 Results 53895 3AMN Healthcare Announces Second Quarter 2009 Results 53895 4AMN Healthcare Announces Second Quarter 2009 Results 53895 5AMN Healthcare Announces Second Quarter 2009 Results 53895 6AMN Healthcare Announces Second Quarter 2009 Results 53895 7AMN Healthcare Announces Second Quarter 2009 Results 53895 8AMN Healthcare Announces Second Quarter 2009 Results 53895 9AMN Healthcare Announces Second Quarter 2009 Results 53895 10AMN Healthcare Announces Second Quarter 2009 Results 53895 11AMN Healthcare Announces Second Quarter 2009 Results 53895 12AMN Healthcare Announces Second Quarter 2009 Results 53895 13AMN Healthcare Announces Second Quarter 2009 Results 53895 14AMN Healthcare Announces Second Quarter 2009 Results 53895 15AMN Healthcare Announces Second Quarter 2009 Results 53895 16
... techniques have brought us the resurgence of Amer...the rescue of prized lobster fisheries. So how can...such failures, from the catastrophic loss of Guate...er salmon kill in 2006" , In this week,s special ...f Sciences (online), Indiana University political ...
...r odious? Is there something in the chemistry of a...erceive its smell? Scientists at the Weizmann Inst...at Berkeley have now discovered that there is, ind...ure of a substance can help predict whether we wil...ght and hearing, for instance, our perceptions are...
...produce cheap, sustainable solar energy by imitati...nia Institute of Technology professor Nate Lewis a...chitecture of grass and photosynthesis to capture ... at how Dr. Lewis and his CalTech research team ar...inexpensive everyday products like house paint and...
Other Biology News:Why conservation efforts often fail 2Sweet smell 2
COX Chemiluminescence Assay Kit from Assay Designs/Stressgen Bioreagents
Goat Anti-p70 S6 Kinase, phospho (Thr229) Polyclonal Antibody, Unconjugated from R&D Systems
Sheep Growth Hormone from Cell Sciences
Anti-Human DPPII / QPP / DPP7 Affinity Purified Polyclonal Antibody, Biotin Conjugated from R&D Systems
Biology Products: